B. Riley Predicts Lineage Cell Therapeutics Q1 Earnings
Lineage Cell Therapeutics, Inc. (NYSEAMERICAN:LCTX – Free Report) – B. Riley issued their Q1 2025 EPS estimates for shares of Lineage Cell Therapeutics in a research report issued on Thursday, March 13th. B. Riley analyst M. Mamtani forecasts that the company will post earnings per share of ($0.03) for the quarter. B. Riley currently has […]
